[The advances in research on phosphorylation of polyglutamine disease]
- PMID: 18683139
[The advances in research on phosphorylation of polyglutamine disease]
Abstract
Polyglutamine (polyQ) diseases are a group of hereditary neurodegenerative disorders caused by expansion of a glutamine repeat in responsible gene products. To date, the pathogenesis of polyQ diseases is still not very clear, but many researches suggest that phosphorylation of mutant proteins plays a critical role on the process of Huntington's disease, dentatorubral-pallidoluysian atrophy, spinal bulbar muscular atrophy, spinocerebellar ataxia1 and spinocerebellar ataxia 3/Machado-Joseph disease.
Similar articles
-
CAG repeat disorder models and human neuropathology: similarities and differences.Acta Neuropathol. 2008 Jan;115(1):71-86. doi: 10.1007/s00401-007-0287-5. Epub 2007 Sep 5. Acta Neuropathol. 2008. PMID: 17786457 Review.
-
Trinucleotide repeats in neurogenetic disorders.Annu Rev Neurosci. 1996;19:79-107. doi: 10.1146/annurev.ne.19.030196.000455. Annu Rev Neurosci. 1996. PMID: 8833437 Review.
-
Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.Neuropathol Appl Neurobiol. 2004 Dec;30(6):665-75. doi: 10.1111/j.1365-2990.2004.00583.x. Neuropathol Appl Neurobiol. 2004. PMID: 15541006
-
Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.Arch Neurol. 2005 Jan;62(1):46-51. doi: 10.1001/archneur.62.1.46. Arch Neurol. 2005. PMID: 15642849 Review.
-
[Molecular biology of polyglutamine diseases].Postepy Hig Med Dosw. 2002;56(6):779-88. Postepy Hig Med Dosw. 2002. PMID: 12661407 Review. Polish.
Cited by
-
Prediction of functional phosphorylation sites by incorporating evolutionary information.Protein Cell. 2012 Sep;3(9):675-90. doi: 10.1007/s13238-012-2048-z. Epub 2012 Jul 16. Protein Cell. 2012. PMID: 22802047 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources